Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data NEUTRA CORP. files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
FY2014
FY2015
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
Revenue
0.01
0.01
0.09
0.07
Cost of revenue
0.04
0.06
0.03
Gross profit
0.01
-0.03
0.03
0.04
General and administrative
0.97
0.64
1.04
0.37
0.16
1.71
0.4
0.41
0.51
0.23
Operating income
-0.97
-0.64
-1.04
-0.37
-0.16
-1.71
-0.39
-0.48
-0.58
-0.3
Interest expense
0.29
1.15
0.4
0.5
0.36
0.72
0.34
0.12
0.06
0.06
Other non-operating income
-1.26
-0.41
-0.5
-0.36
-0.72
-0.3
-0.06
-0.05
-0.26
Pre-tax income
-0.63
-0.56
Income tax
0
0
0
Net income
-1.26
-1.9
-1.44
-0.87
-0.52
-2.43
-0.7
-0.54
-0.63
-0.56
EBITDA
-0.45
-0.51
-0.22
EPS, basic
-6.24
-3.36
-1.25
-0.41
-0.10
-0.16
0.00
0.00
EPS, diluted
-6.24
-3.36
-1.25
-0.41
-0.10
-0.16
0.00
0.00
Shares, basic (weighted)
0.2
0.56
1.15
2.14
5.26
14.9
242
1,193
Shares, diluted (weighted)
0.2
0.56
1.15
2.14
5.26
14.9
242
1,193
Balance sheet
FY2014
FY2015
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
Cash and equivalents
0.05
0.01
0
0
0
0
0.18
0.02
0
0
Receivables
0
Inventory
0
0.02
Total current assets
0.05
0.01
0
0.01
0.16
0.18
0.02
0
0.03
Property, plant and equipment
0.17
0.13
0.05
Total assets
0.05
0.01
0
0
0.01
0.16
0.18
0.19
0.13
0.08
Accounts payable
0.24
0.33
0.39
0.47
0.46
0.46
0.41
0.43
0.13
0.23
Short-term debt
0.1
Total current liabilities
0.34
0.34
0.4
0.63
0.75
1.27
1.03
1
1.15
0.76
Long-term debt
0.05
Total liabilities
0.55
0.39
0.43
0.68
0.78
1.27
1.03
1
1.15
0.81
Total debt
0.48
0.52
Paid-in capital
1.2
3.15
4.62
5.24
5.66
7.72
8.09
7.43
7.82
7.89
Retained earnings
-1.71
-3.6
-5.05
-5.92
-6.43
-8.86
-9.56
-10.1
-10.9
-11.5
Shareholders' equity
-0.5
-0.39
-0.43
-0.68
-0.76
-1.11
-0.85
-0.97
-1.27
-0.77
Total equity
-0.5
-0.39
-0.43
-0.68
-0.76
-1.11
-0.85
-0.97
-1.27
-0.77
Total liabilities and equity
0.05
0.01
0
0
0.01
0.16
0.18
0.19
0.13
0.08
Shares outstanding
0.31
0.9
1.72
2.98
6.84
34.1
616
1,493
1,782
2,744
Cash flow statement
FY2014
FY2015
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
Net income
-1.26
-1.9
-1.44
-0.87
-0.52
-2.43
-0.7
-0.54
-0.63
-0.56
Depreciation and amortization
0.03
0.08
0.08
Change in receivables
-0
0
Change in inventory
-0
0
-0.02
Change in payables
0.17
0.09
0.06
0.12
-0.01
0
0.03
0.1
-0.01
Cash from operations
-0.8
-0.55
-0.49
-0.21
-0.11
-0.42
-0.18
-0.41
-0.41
-0.15
Capital expenditures
-0.2
-0.04
Acquisitions
-0.11
-0.01
Cash from investing
-0.11
-0.01
-0.2
-0.04
Cash from financing
0.84
0.62
0.49
0.21
0.11
0.42
0.36
0.46
0.42
0.15
Net change in cash
0.04
-0.04
-0.01
-0
0.18
-0.15
-0.02
0
Free cash flow
-0.61
-0.45
Interest paid
0.02
0
Key metrics
Worked out from the statements above. Latest values use the trailing twelve months to October 31, 2023; growth uses fiscal years. Valuation uses the share price of $0.00 on September 25, 2026.
Profitability
Metric
Value
How it is calculated
Gross margin
46.2%
Gross profit / revenue.
Operating margin
-1,457.0%
Operating income / revenue.
EBITDA margin
-1,103.0%
EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin
-2,700.0%
Pre-tax income / revenue.
Net margin
-2,724.0%
Net income / revenue.
Operating cash flow margin
-56.1%
Cash from operations / revenue.
Return on assets (ROA)
-1,759.0%
Net income / average total assets.
D&A / revenue
353.8%
Depreciation and amortization / revenue.
Growth
Metric
Value
How it is calculated
Revenue growth, 1y
-26.1%
Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y
119.9%
Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit growth, 1y
13.3%
Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y
76.7%
Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets growth, 1y
-42.6%
Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y
-25.6%
Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y
43.6%
Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Balance sheet health
Metric
Value
How it is calculated
Current ratio
0.02x
Current assets / current liabilities.
Quick ratio
0.00x
(Cash + short-term investments + receivables) / current liabilities.
Cash ratio
0.00x
(Cash + short-term investments) / current liabilities.
Market cap + total debt - cash - short-term investments.
P/S
16.8x
Market cap / revenue.
EV/Sales
16.7x
Enterprise value / revenue.
Earnings yield
-162.4%
Net income / market cap (the inverse of P/E).
What was NEUTRA CORP.'s revenue in fiscal 2023?
NEUTRA CORP. reported revenue of $68.0K for fiscal 2023, 26.1% lower than the year before.
Was NEUTRA CORP. profitable in fiscal 2023?
No. It reported a net loss of $561.4K.
Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.